Host genetic background regulates the capacity for anti-tumor antibody-dependent phagocytosis
J. E. Glassbrook, J. B. Hackett, M. C. Muniz, M. Bross, G. Dyson, N. Movahhedin, A. Ullrich, H. M. Gibson
This study shows host genetics influence anti-tumor antibody therapy effectiveness by affecting macrophage phagocytosis capacity in mouse models.
bioRxiv · May 9, 2023 · PreprintCancer Biology